Online Ketamine Treatment Available in: AZ, CA, CO, FL, GA, NY, OR, TX, and WA.
Online Ketamine Treatment Available in: AZ, CA, CO, FL, GA, NY, OR, TX, and WA.
FOR PATIENTS
Make an AppointmentPricingOUR TREATMENT APPROACHExpert insights on ketamine therapy, depression, anxiety, PTSD, and mental health treatment — updated regularly by the Isha Health clinical team.
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) are being studied for effects on depression, anxiety, and addiction. Here's what the research shows so far.
Isha Health is out-of-network, but you may still get reimbursed. Learn how a superbill works, what to expect from your insurer, and how to submit your claim
What does the research say about ashwagandha for depression? We cover the Lopresti 2017 study, recommended dosage ranges, the BDNF connection, standardized extracts, and realistic timelines.
Can ketamine treat PTSD? A physician's guide to the research, how it compares to EMDR, and what at-home ketamine therapy looks like.
A clinical guide to ashwagandha side effects, drug interactions, contraindications, liver safety concerns, and how to choose a quality supplement.
Can ashwagandha replace antidepressants like SSRIs? We compare mechanisms, evidence strength, and risks, and explain why stopping prescribed medication for a supplement can be dangerous.
Does ashwagandha actually help with anxiety? We review the clinical evidence, including key studies on cortisol reduction and GABAergic activity, dosage recommendations, and who should avoid it.
A landmark Cell Reports study found that psychedelics including ketamine and psilocybin promote structural and functional neural plasticity. Here is how they compare and what it means for treatment.
Research is identifying clinical predictors of ketamine response in treatment-resistant depression, including BMI, family history, and anxiety features. Here is what the evidence shows.
Emerging research suggests ketamine may influence gut microbiome composition, and that the gut-brain axis could play a role in its antidepressant effects. Here is what we know so far.
A Phase 3 trial published in Nature Medicine found that MDMA-assisted therapy produced significant improvements in severe PTSD. Here is a detailed look at the study and what it means.
The largest psilocybin trial for treatment-resistant depression, published in the New England Journal of Medicine, showed significant results at the 25mg dose. Here is what the data reveals.
Page 1 of 16
This website has been reviewed by Isha Health California, P.C. and should not be used as medical advice in place of a licensed psychiatric clinician.
IN CASE OF EMERGENCY:
If you are in a life-threatening situation, don't use this site. Call, text, or chat 988 or 1-800-273-TALK (8255), or use these resources to get immediate help.